Beyond Yellow Curry: Assessing Commercial Curcumin Absorption Technologies

REFERENCES

• Ringman JM, Frautschy SA, Teng E, Begum AN, Bardens J, Beigi M, Gylys KH, Badmaev V, Heath DD, Apostolova LG, Porter V, Vanek Z, Marshall GA, Hellemann G, Sugar C, Masterman DL, Montine TJ, Cummings JL, Cole GM: Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study. Alzheimers Res Ther 4:1–8, 2012.
   PubMedGoogle Scholar
• Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB: Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818, 2007.
   PubMed Web of Science ®Google Scholar
• Mattes RD: Fat taste in humans: is it a primary? In: Montmayeur JP, le Coutre J (eds): “Fat Detection: Taste, Texture, and Post Ingestive Effects.” Boca Raton, FL: CRC Press, 2010. Accessed at http://www.ncbi.nlm.nih.gov/books/NBK53546/
   Google Scholar
• Ireson CR, Jones DJ, Orr S, Coughtrie MW, Boocock DJ, Williams ML, Farmer PB, Steward WP, Gescher AJ: Metabolism of the cancer chemopreventive agent curcumin in human and rat intestine. Cancer Epidemiol Biomarkers Prev 11:105–111, 2002.
   PubMed Web of Science ®Google Scholar
• Pan MH, Huang TM, Lin JK: Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos 27:486–494, 1999.
   PubMed Web of Science ®Google Scholar
• Wahlström B, Blennow G: A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol (Copenh) 43:86–92, 1978.
   PubMedGoogle Scholar
• Vareed SK, Kakarala M, Ruffin MT, Crowell JA, Normolle DP, Djuric Z, Brenner DE: Pharmacokinetics of curcumin conjugate metabolites in healthy human subjects. Cancer Epidemiol Biomarkers Prev 17:1411–1417, 2008.
   PubMed Web of Science ®Google Scholar
• Holder GM, Plummer JL, Ryan AJ: The metabolism and excretion of curcumin (1,7-bis-(4-hydroxy-3-methoxyphenyl)-1,6-heptadiene-3,5-dione) in the rat. Xenobiotica 8:761–768, 1978.
   PubMed Web of Science ®Google Scholar
• Hoehle SI, Pfeiffer E, Solyom AM, Metzler M: Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem 54:756–764, 2007.
   Web of Science ®Google Scholar
• Hassaninasab A, Hashimoto Y, Tomita-Yokotani K, Kobayashi M: Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A 108:6615–6620, 2011.
   PubMed Web of Science ®Google Scholar
• Kumar A, Ahuja A, Ali J, Baboota S: Conundrum and therapeutic potential of curcumin in drug delivery. Crit Rev Ther Drug Carrier Syst 27:279–312, 2010.
   PubMed Web of Science ®Google Scholar
• Dhule SS, Penfornis P, Frazier T, Walker R, Feldman J, Tan G, He J, Alb A, John V, Pochampally R: Curcumin-loaded γ-cyclodextrin liposomal nanoparticles as delivery vehicles for osteosarcoma. Nanomedicine 8:440–451, 2012.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC: Curcumin nanoformulations: a future nanomedicine for cancer. Drug Discov Today 17:71–80, 2012.
   PubMed Web of Science ®Google Scholar
• Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, Ko JY, Lin JT, Lin BR, Ming-Shiang W, Yu HS, Jee SH, Chen GS, Chen TM, Chen CA, Lai MK, Pu YS, Pan MH, Wang YJ, Tsai CC, Hsieh CY: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21:2895–2900, 2001.
   PubMed Web of Science ®Google Scholar
• Garcea G, Berry DP, Jones DJ, Singh R, Dennison AR, Farmer PB, Sharma RA, Steward WP, Gescher AJ: Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14:120–125, 2005.
   PubMed Web of Science ®Google Scholar
• Lao CD, Ruffin MT IV, Normolle D, Heath DD, Murray SI, Bailey JM, Boggs ME, Crowell J, Rock CL, Brenner DE: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 17:6–10, 2006.
   Google Scholar
• Kanai M, Yoshimura K, Asada M, Imaizumi A, Suzuki C, Matsumoto S, Nishimura T, Mori Y, Masui T, Kawaguchi Y, Yanagihara K, Yazumi S, Chiba T, Guha S, Aggarwal BB: A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer. Cancer Chemother Pharmacol 68:157–164, 2011.
   PubMed Web of Science ®Google Scholar
• Yu H, Huang Q: Improving the oral bioavailability of curcumin using novel organogel-based nanoemulsions. J Agric Food Chem 60:5373–5379, 2012.
   PubMed Web of Science ®Google Scholar
• Schiborr C, Kocher A, Behnam D, Jandasek J, Toelstede S, Frank J: The oral bioavailability of curcumin from micronized powder and liquid micelles is significantly increased in healthy humans and differs between sexes. Mol Nutr Food Res 68:157–164, 2014.
   Google Scholar
• Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, Togni S, Dixon BM: Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 74:664–669, 2011.
   PubMed Web of Science ®Google Scholar
• Sasaki H, Sunagawa Y, Takahashi K, Imaizumi A, Fukuda H, Hashimoto T, Wada H, Katanasaka Y, Kakeya H, Fujita M, Hasegawa K, Morimoto T: Innovative preparation of curcumin for improved oral bioavailability. Biol Pharm Bull 34:660–665, 2011.
   PubMed Web of Science ®Google Scholar
• Türeli AE: “Characterization of Curcumin Formulations” [Confidential Report]. Homburg, Germany: MJR PharmJet GmbH. 2011.
   Google Scholar
• Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S: A pilot cross-over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), a novel bioenhanced preparation of curcumin. Indian J Pharm Sci 70:445–449, 2008.
   PubMed Web of Science ®Google Scholar
• Benny M, Antony B: Bioavailability of BIOCURCUMAXTM (BCM–095TM). Spice India 19:11–15, 2006.
   Google Scholar
• Mukkadan JK: Bioavailability of CURCU-GELTM Softsules→ Containing (BCM-95). 2007. Unpublished results.
   Google Scholar
• Volak LP, Hanley MJ, Masse G, Hazarika S, Harmatz JS, Badmaev V, Majeed M, Greenblatt DJ, Court MH: Effect of an herbal extract containing curcumin and piperine on midazolam, flurbiprofen, and acetaminophen pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 17:1411–1417, 2012.
   Google Scholar
• Giori A, Franceschi F: “Phospholipid Complexes of Curcumin Having Improved Bioavailability.” Patent Application WO 2007/101551, September 13, 2007.
   Google Scholar
• Wang YJ, Pan MH, Cheng AL, Lin LI, Ho YS, Hsieh CY, Lin JK: Stability of curcumin in buffer solutions and characterization of its degradation products. J Pharm Biomed Anal 15:1867–1876, 1997.
   PubMed Web of Science ®Google Scholar
• Semalty A, Semalty M, Rawat MS, Franceschi F: Supramolecular phospholipids–polyphenolics interactions: the PHYTOSOME strategy to improve the bioavailability of phytochemicals. Fitoterapia 81:306–314, 2010.
   PubMed Web of Science ®Google Scholar
• Aura AM: Microbial metabolism of dietary phenolic compounds in the colon. Phytochem Rev 7:407–429, 2007.
   Google Scholar
• Possemiers S, Bolca S, Verstraete W, Heyerick A: The intestinal microbiome: a separate organ inside the body with the metabolic potential to influence the bioactivity of botanicals. Fitoterapia 82:53–66, 2011.
   PubMed Web of Science ®Google Scholar
• Kidd P, Head K: A review of the bioavailability and clinical efficacy of milk thistle phytosome: a silybin-phosphatidylcholine complex (Siliphos). Altern Med Rev 10:193–203, 2005.
   PubMed Web of Science ®Google Scholar
• Marczylo TH, Verschoyle RD, Cooke DN, Morazzoni P, Steward WP, Gescher AJ: Comparison of systemic availability of curcumin with that of curcumin formulated with phosphatidylcholine. Cancer Chemother Pharmacol 60:171–177, 2007.
   PubMed Web of Science ®Google Scholar
• Singh R, Tønnesen H, Vogensen S, Loftsson T, Másson M: Studies of curcumin and curcuminoids. The stoichiometry and complexation constants of cyclodextrin complexes as determined by the phase-solubility method and UV-Vis titration. J Incl Phenom Macrocycl Chem 66:335–348, 2010.
   Web of Science ®Google Scholar
• Desai K: “Curcumin Cyclodextrin Combination for Preventing or Treating Various Diseases.” US Patent Application US20100179103, July 15, 2010.
   Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC: beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells. Colloids Surf B Biointerfaces 79:113–125, 2010.
   PubMed Web of Science ®Google Scholar
• CAVAMAX®. W8 curcumin-complex cyclodextrins. Accessed at: http://www.wacker.com/cms/en/products/product/product.jsp?product=13747
   Google Scholar
• Gota VS, Maru GB, Soni TG, Gandhi TR, Kochar N, Agarwal MG: Safety and pharmacokinetics of a solid lipid curcumin particle formulation in osteosarcoma patients and healthy volunteers. J Agric Food Chem 24:2095–2099, 2010.
   Web of Science ®Google Scholar
• The Longvida® breakthrough. Accessed at: http://longvida.com/the-breakthrough/
   Google Scholar
• Ankola DD, Viswanad B, Bhardwaj V, Ramarao P, Kumar MN: Development of potent oral nanoparticulate formulation of coenzyme Q10 for treatment of hypertension: can the simple nutritional supplements be used as first line therapeutic agents for prophylaxis/therapy? Eur J Pharm Biopharm 67:361–369, 2007.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS: A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33–48, 2003.
   PubMed Web of Science ®Google Scholar
• Bala I, Bhardwaj V, Hariharan S, Kharade SV, Roy N, Ravi Kumar MN: Sustained release nanoparticulate formulation containing antioxidant-ellagic acid as potential prophylaxis system for oral administration. J Drug Target 14:27–34, 2006.
   PubMed Web of Science ®Google Scholar
• Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hashiguchi M, Tsujiko K, Matsumoto S, Ishiguro H, Chiba T: Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers. Cancer Chemother Pharmacol 69:65–70, 2012.
   PubMed Web of Science ®Google Scholar
• Inkyoa M, Tahara T, Iwaki T, Iskandar F, Hogan CJ Jr, Okuyama K: Experimental investigation of nanoparticle dispersion by beads milling with centrifugal bead separation. J Colloid Interface Sci 304:535–540, 2006,
   PubMed Web of Science ®Google Scholar
• Deshpande JV, Kulkarni SK: “Water Soluble Composition Comprising Curcumin Having Enhanced Bioavailability and Process Thereof.” US Patent Application 20130274343, 2013.
   Google Scholar
• Kulkarni SK, Akula KK, Deshpande J: Evaluation of antidepressant-like activity of novel water-soluble curcumin formulations and St. John's wort in behavioral paradigms of despair. Pharmacology 89:83–90, 2012.
   PubMed Web of Science ®Google Scholar
• Jäger R, Lowery RP, Calvanese A, Joy JM, Purpura M, Wilson JM: Comparative absorption of curcumin formulations. Nutr J 13:1–8, 2014.
   PubMed Web of Science ®Google Scholar
• Juturu V: Absorption of different curcumin formulations. International Standard Randomised Controlled Trial Number Register: ISRCTN28011391.
   Google Scholar
• Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester–induced prostaglandin E2 production. Cancer Res 61:1058–1064, 2001.
   PubMed Web of Science ®Google Scholar
• Sandur SK, Pandey MK, Sung B, Ahn KS, Murakami A, Sethi G, Limtrakul P, Badmaev V, Aggarwal BB: Curcumin, demethoxycurcumin, bisdemothoxycurcumin, tetrahydrocurcumin, and turmerones differentially regulate anti-inflammatory and antiproliferative responses through a ROS-independent mechanism. Carcinogenesis 28:1765–1773, 2007.
   PubMed Web of Science ®Google Scholar
• Sugiyama Y, Kawakishi S, Osawa T: Involvement of the beta-diketone moiety in the antioxidative mechanism of tetrahydrocurcumin. Biochem Pharmacol 52:519–525, 1996.
   PubMed Web of Science ®Google Scholar
• Pfeiffer E, Hoehle SI, Walch SG, Riess A, Sólyom AM, Metzler M: Curcuminoids form reactive glucuronides in vitro. J Agric Food Chem 55:538–544, 2007.
   PubMed Web of Science ®Google Scholar
• Kim JM, Araki S, Kim DJ, Park CB, Takasuka N, Baba-Toriyama H, Ota T, Nir Z, Khachik F, Shimidzu N, Tanaka Y, Osawa T, Uraji T, Murakoshi M, Nishino H, Tsuda H: Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19:81–85, 1998.
   PubMed Web of Science ®Google Scholar
• Pari L, Amali DR: Protective role of tetrahydrocurcumin (THC) an active principle of turmeric on chloroquine induced hepatotoxicity in rats. J Pharm Pharm Sci 8:115–123, 2005.
   PubMed Web of Science ®Google Scholar
• Murugan P, Pari L: Effect of tetrahydrocurcumin on plasma antioxidants in streptozotocin–nicotinamide experimental diabetes. J Basic Clin Physiol Pharmacol 17:231–244, 2006.
   PubMedGoogle Scholar
• Ryu MJ, Cho M, Song JY, Yun YS, Choi IW, Kim DE, Park BS, Oh S: Natural derivatives of curcumin attenuate the Wnt/β-catenin pathway through down-regulation of the transcriptional coactivator p300. Biochem Biophys Res Commun 377:1304–1308, 2008.
   PubMed Web of Science ®Google Scholar
• Fiala M, Liu PT, Espinosa-Jeffrey A, Rosenthal MJ, Bernard G, Ringman JM, Sayre J, Zhang L, Zaghi J, Dejbakhsh S, Chiang B, Hui J, Mahanian M, Baghaee A, Hong P, Cashman J: Innate immunity and transcription of MGAT-III and Toll-like receptors in Alzheimer's disease patients are improved by bisdemethoxycurcumin. Proc Natl Acad Sci USA 104:12849–12854, 2007.
   Google Scholar
• Mahattanadul S, Nakamura T, Panichayupakaranant P, Phdoongsombut N, Tungsinmunkong K, Bouking P: Comparative antiulcer effect of bisdemethoxycurcumin and curcumin in a gastric ulcer model system. Phytomedicine 16:342–351, 2009.
   PubMed Web of Science ®Google Scholar
• Sharma RA, McLelland HR, Hill KA, Ireson CR, Euden SA, Manson MM, Pirmohamed M, Marnett LJ, Gescher AJ, Steward WP: Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res 7(7):1894–1900, 2001.
   PubMed Web of Science ®Google Scholar
• Mohammadi A, Sahebkar A, Iranshahi M, Amini M, Khojasteh R, Ghayour-Mobarhan M, Ferns GA: Effects of supplementation with curcuminoids on dyslipidemia in obese patients: a randomized crossover trial. Phytother Res 27:374–379, 2013.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, Marczylo TH, Morgan B, Hemingway D, Plummer SM, Pirmohamed M, Gescher AJ, Steward WP: Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res 10:6847–6854, 2004.
   PubMed Web of Science ®Google Scholar
• Metzler M, Pfeiffer E, Schulz SI, Dempe JS: Curcumin uptake and metabolism. Biofactors 39:14–20, 2013.
   PubMed Web of Science ®Google Scholar
• Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, Rock CL, Pruitt MA, Yang F, Hudspeth B, Hu S, Faull KF, Teter B, Cole GM, Frautschy SA: Curcumin structure–function, bioavailability, and efficacy in models of neuroinflammation and Alzheimer's disease. J Pharmacol Exp Ther 326:196–208, 2008.
   PubMed Web of Science ®Google Scholar
• Pari L, Murugan P: Influence of Tetrahydrocurcumin on tail tendon collagen contents and its properties in rats with streptozotocin–nicotinamide induced type 2 diabetes. Fundam Clin Pharmacol 21:665–671, 2007.
   PubMed Web of Science ®Google Scholar
• Pari L, Murugan P: Antihyperlipidemic effect of curcumin and tetrahydrocurcumin in experimental type 2 diabetic rats. Ren Fail 29:881–889, 2007.
   PubMed Web of Science ®Google Scholar
• Ireson C, Orr S, Jones DJ, Verschoyle R, Lim CK, Luo JL, Howells L, Plummer S, Jukes R, Williams M, Steward WP, Gescher A: Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester–induced prostaglandin E2 production. Cancer Res 61:1058–1064, 2001.
   PubMed Web of Science ®Google Scholar
• Thompson Reuters: “National Survey of Supplement Consumers for National Public Radio (The Shots).” New York: Thompson Reuters, 2010.
   Google Scholar